1-9 of 9
Ayalew Tefferi, M.D.
Close
Sort by
Journal Articles

Early Peripheral Blood Blast Clearance during Induction Chemotherapy for Acute Myeloid Leukemia (AML) Predicts Superior Relapse-Free Survival.

Michelle A. Elliott, MD, Mark R. Litzow, M.D., Louis Letendre, M.D., Robert C. Wolf, Curtis A. Hanson, M.D., Ayalew Tefferi, M.D., Martin S. Tallman, M.D.
Journal: Blood
Blood (2007) 110 (11): 1848.
https://doi.org/10.1182/blood.V110.11.1848.1848
Published: 2007
Journal Articles

Phase II Study of CEP701, an Orally Available JAK2 Inhibitor, in Patients with Primary Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis.

Srdan Verstovsek, MD, PhD, Ayalew Tefferi, M.D., Steven Kornblau, M.D., Deborah Thomas, M.D., Jorge Cortes, M.D., Farhad Ravandi-Kashani, M.D., Guillermo Garcia-Manero, M.D., Hagop Kantarjian, M.D.
Journal: Blood
Blood (2007) 110 (11): 3543.
https://doi.org/10.1182/blood.V110.11.3543.3543
Published: 2007
Journal Articles

Phase II Study of Lenalidomide and Prednisone for Patients with Myelofibrosis.

Alfonso Quintás-Cardama, MD, Ayalew Tefferi, M.D., Deborah Thomas, M.D., Jorge Cortes, M.D., Farhad Ravandi, M.D., Stefan Faderl, M.D., Guillermo Garcia-Manero, M.D., Gautam Borthakur, M.D., Neda Bell, M.D., Catriona Byrne, M.D., Hagop Kantarjian, M.D., Srdan Verstovsek, M.D., Ph.D
Journal: Blood
Blood (2007) 110 (11): 3545.
https://doi.org/10.1182/blood.V110.11.3545.3545
Published: 2007
Journal Articles

Dasatinib (Sprycel™) Therapy for Patients with Systemic Mastocytosis.

Srdan Verstovsek, MD, PhD, Hagop Kantarjian, M.D., Jorge Cortes, M.D., Farhad Ravandi-Kashani, M.D., Gautam Borthakur, M.D., Claude Nicaise, M.D., Inga Sams, M.D., Francis Giles, M.D., Ayalew Tefferi, M.D.
Journal: Blood
Blood (2006) 108 (11): 3627.
https://doi.org/10.1182/blood.V108.11.3627.3627
Published: 2006
Journal Articles

Additional Cytogenetic Abnormalities and/or Philadelphia Chromosome Metaphase Mosaicism Might Adversely Influence Survival and Imatinib Response in Chronic Myeloid Leukemia.

Andrew P. Landstrom, BS, Rhett P. Ketterling, M.D., Ryan A. Knudson, B.A., Gordon W. Dewald, Ph.D., Ayalew Tefferi, M.D.
Journal: Blood
Blood (2006) 108 (11): 4783.
https://doi.org/10.1182/blood.V108.11.4783.4783
Published: 2006
Journal Articles

Alemtuzumab (CAMPATH-1H ™ ) Is Effective Therapy for Hypereosinophilic Syndrome (HES).

Alfonso Quintas-Cardama, MD, Ayalew Tefferi, M.D., Jorge Cortes, M.D., Animesh Pardanani, M.D., Farhad Ravandi-Kashani, M.D., Francis Giles, M.D., Pat Ault, R.N., Hagop Kantarjian, M.D., Srdan Verstovsek, M.D.;PhD
Journal: Blood
Blood (2006) 108 (11): 4902.
https://doi.org/10.1182/blood.V108.11.4902.4902
Published: 2006
Journal Articles

Efficacy of Conventional Cytogenetics and FISH for EGR1 To Detect Deletion 5q in Hematological Disorders and To Assess Response to Treatment with Lenalidomide.

Ying Zou, MD, Stephanie Fink, Kimberly Stockero, Sarah Paternoster, Stephanie Smoley, Han Tun, M.D., Craig Reeder, M.D., Ayalew Tefferi, M.D., Gordon Dewald, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2351.
https://doi.org/10.1182/blood.V108.11.2351.2351
Published: 2006
Journal Articles

Allogeneic Stem Cell Transplantation (SCT) in Untreated First Relapse or Following Re-Induction Chemotherapy for Patients with Acute Myeloid Leukemia (AML).

Rachanid Pornvipavee, M.D., Walter K. Kremers, Ph.D., Rachel A. Pedersen, Michelle Elliott, M.D., William J. Hogan, M.D., Ayalew Tefferi, M.D., Mark Robert Litzow, M.D.
Journal: Blood
Blood (2004) 104 (11): 5143.
https://doi.org/10.1182/blood.V104.11.5143.5143
Published: 2004
Journal Articles

A Phase I Trial of Autologous Dendritic Cell Therapy for Chronic Myelogenous Leukemia.

Mark Robert Litzow, M.D., Allan B. Dietz, Ph.D., Peggy A. Bulur, Greg W. Butler, Stephanie R. Fink, Louis Letendre, M.D., Sarah F. Paternoster, Ayalew Tefferi, M.D., Antje Hoering, Ph.D., Stanimir Vuk-Pavlovic, Ph.D.
Journal: Blood
Blood (2004) 104 (11): 2931.
https://doi.org/10.1182/blood.V104.11.2931.2931
Published: 2004